Literature DB >> 35277681

Advances in local therapy for glioblastoma - taking the fight to the tumour.

Thomas S van Solinge1,2, Lisa Nieland3,4, E Antonio Chiocca5, Marike L D Broekman3,4,6.   

Abstract

Despite advances in neurosurgery, chemotherapy and radiotherapy, glioblastoma remains one of the most treatment-resistant CNS malignancies, and the tumour inevitably recurs. The majority of recurrences appear in or near the resection cavity, usually within the area that received the highest dose of radiation. Many new therapies focus on combatting these local recurrences by implementing treatments directly in or near the tumour bed. In this Review, we discuss the latest developments in local therapy for glioblastoma, focusing on recent preclinical and clinical trials. The approaches that we discuss include novel intraoperative techniques, various treatments of the surgical cavity, stereotactic injections directly into the tumour, and new developments in convection-enhanced delivery and intra-arterial treatments.
© 2022. Springer Nature Limited.

Entities:  

Mesh：

Year:  2022        PMID： 35277681     DOI： 10.1038/s41582-022-00621-0

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   44.711


  136 in total

1.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

2.  Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.

Authors:  Sandeep Mittal; Neil V Klinger; Sharon K Michelhaugh; Geoffrey R Barger; Susan C Pannullo; Csaba Juhász
Journal:  J Neurosurg       Date:  2017-02-24       Impact factor: 5.115

Review 3.  Multidimensional communication in the microenvirons of glioblastoma.

Authors:  Marike L Broekman; Sybren L N Maas; Erik R Abels; Thorsten R Mempel; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

Review 4.  Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target.

Authors:  Melanie Jackson; Foteini Hassiotou; Anna Nowak
Journal:  Carcinogenesis       Date:  2014-12-11       Impact factor: 4.944

5.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

6.  Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status.

Authors:  Alba A Brandes; Alicia Tosoni; Enrico Franceschi; Guido Sotti; Giampiero Frezza; Pietro Amistà; Luca Morandi; Federica Spagnolli; Mario Ermani
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

7.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

8.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

9.  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

Authors:  Roger Stupp; Sophie Taillibert; Andrew A Kanner; Santosh Kesari; David M Steinberg; Steven A Toms; Lynne P Taylor; Frank Lieberman; Antonio Silvani; Karen L Fink; Gene H Barnett; Jay-Jiguang Zhu; John W Henson; Herbert H Engelhard; Thomas C Chen; David D Tran; Jan Sroubek; Nam D Tran; Andreas F Hottinger; Joseph Landolfi; Rajiv Desai; Manuela Caroli; Yvonne Kew; Jerome Honnorat; Ahmed Idbaih; Eilon D Kirson; Uri Weinberg; Yoram Palti; Monika E Hegi; Zvi Ram
Journal:  JAMA       Date:  2015-12-15       Impact factor: 56.272

10.  Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.

Authors:  Ping Zhu; Xianglin L Du; Guangrong Lu; Jay-Jiguang Zhu
Journal:  Oncotarget       Date:  2017-07-04
View more
  9 in total

Review 1.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

Review 2.  Updates in IDH-Wildtype Glioblastoma.

Authors:  Mary Jane Lim-Fat; James R Perry; Jawad M Melhem; Jay Detsky
Journal:  Neurotherapeutics       Date:  2022-05-31       Impact factor: 6.088

Review 3.  Glioblastoma Treatment: State-of-the-Art and Future Perspectives.

Authors:  Alejandro Rodríguez-Camacho; José Guillermo Flores-Vázquez; Júlia Moscardini-Martelli; Jorge Alejandro Torres-Ríos; Alejandro Olmos-Guzmán; Cindy Sharon Ortiz-Arce; Dharely Raquel Cid-Sánchez; Samuel Rosales Pérez; Monsserrat Del Sagrario Macías-González; Laura Crystell Hernández-Sánchez; Juan Carlos Heredia-Gutiérrez; Gabriel Alejandro Contreras-Palafox; José de Jesús Emilio Suárez-Campos; Miguel Ángel Celis-López; Guillermo Axayacalt Gutiérrez-Aceves; Sergio Moreno-Jiménez
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

Review 4.  Neutrophils: New Critical Regulators of Glioma.

Authors:  Guanyu Wang; Jinpeng Wang; Chaoshi Niu; Yan Zhao; Pengfei Wu
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 5.  Local Drug Delivery Strategies for Glioblastoma Treatment.

Authors:  Gi Doo Cha; Sonwoo Jung; Seung Hong Choi; Dae-Hyeong Kim
Journal:  Brain Tumor Res Treat       Date:  2022-07

Review 6.  Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review).

Authors:  Tianzhen Hua; Huanxiao Shi; Mengmei Zhu; Chao Chen; Yandong Su; Shengjia Wen; Xu Zhang; Juxiang Chen; Qilin Huang; Hongxiang Wang
Journal:  Int J Oncol       Date:  2022-07-20       Impact factor: 5.884

Review 7.  Tumor-derived small extracellular vesicles: potential roles and mechanism in glioma.

Authors:  Xu Guo; Rui Sui; Haozhe Piao
Journal:  J Nanobiotechnology       Date:  2022-08-23       Impact factor: 9.429

Review 8.  Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy.

Authors:  Wenhao Liao; Yuchen Li; Jing Wang; Maoyuan Zhao; Nianzhi Chen; Qiao Zheng; Lina Wan; Yu Mou; Jianyuan Tang; Zhilei Wang
Journal:  Int J Nanomedicine       Date:  2022-09-14

9.  Isolation and characterization of an anti-proliferative polysaccharide from the North American fungus Echinodontium tinctorium.

Authors:  Mehreen Zeb; Wai Ming Li; Christian Heiss; Ian Black; Linda E Tackaberry; Hugues B Massicotte; Keith N Egger; Kerry Reimer; Parastoo Azadi; Chow H Lee
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.